EHC Encompass Health Corp

  1. Stocks
  2. Healthcare
  3. NYSE: EHC

Price (delayed)

$100.07

Market cap

$9.93B

P/E Ratio

16.46

Dividend/share

$0.74

EPS

$6.08

Enterprise value

$12.55B

?
Relative Growth: Rel. Growth: 92
Relative Strength: Rel. Strength: 30
Relative Valuation: Rel. Valuation: 79
Relative Profitability: Rel. Profitability: 72

Encompass Health Corporation , based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states ...

Highlights
Encompass Health's EPS has increased by 24% YoY and by 8% from the previous quarter
Encompass Health's net income has increased by 23% YoY and by 8% from the previous quarter
The debt has grown by 3.2% YoY and by 2.8% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: https://www.encompasshealth.com/
Peers: SEM NUTX

Key stats

What are the main financial stats of EHC

EHC stock price

How has the Encompass Health stock price performed over time
Intraday
-3%
1 week
-5.02%
1 month
-6.16%
1 year
-17.48%
YTD
-5.72%
QTD
3.45%

Financial performance

How have Encompass Health's revenue and profit performed over time
Revenue
$6.07B
Gross profit
$1.67B
Operating income
$1.09B
Net income
$609.2M
Gross margin
27.5%
Net margin
10%
Encompass Health's net income has increased by 23% YoY and by 8% from the previous quarter
Encompass Health's operating income has increased by 18% YoY and by 3.3% from the previous quarter
EHC's gross profit is up by 15% YoY and by 3% from the previous quarter
The net margin has grown by 11% YoY and by 5% from the previous quarter

Price vs fundamentals

How does EHC's price correlate with its fundamentals

Growth

What is Encompass Health's growth rate over time

Valuation

What is Encompass Health stock price valuation
EHC P/E details
P/E
16.46
P/B
3.95
P/S
1.64
EV/EBIT
13.35
EV/EBITDA
9.84
EV/Sales
2.07
Encompass Health's EPS has increased by 24% YoY and by 8% from the previous quarter
The P/E is 17% below the last 4 quarters average of 20.5 and 14% below the 5-year quarterly average of 19.8
The company's equity rose by 17% YoY and by 3.4% QoQ
EHC's price to book (P/B) is 15% lower than its last 4 quarters average of 4.8 and 5% lower than its 5-year quarterly average of 4.3
EHC's P/S is 11% below its last 4 quarters average of 1.9
Encompass Health's revenue has increased by 10% YoY and by 2.2% QoQ

Efficiency

How efficient is Encompass Health business performance
Encompass Health's return on assets has increased by 14% YoY and by 4.8% QoQ
The ROIC has grown by 13% YoY and by 4% from the previous quarter
Encompass Health's ROS has increased by 9% YoY and by 4% from the previous quarter
Encompass Health's ROE has increased by 3.3% from the previous quarter and by 2.4% YoY

Dividends

What is EHC's dividend history
Dividend details
DPS
$0.74
Dividend yield
0.74%
Payout ratio
12.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Encompass Health financials performed over time
The total assets is 85% greater than the total liabilities
Encompass Health's quick ratio has increased by 12% QoQ and by 10% YoY
EHC's current ratio is up by 10% year-on-year and by 8% since the previous quarter
The debt is 11% more than the equity
The company's equity rose by 17% YoY and by 3.4% QoQ
Encompass Health's debt to equity has decreased by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.